Invention Grant
- Patent Title: Prognostic method
-
Application No.: US15771622Application Date: 2016-10-28
-
Publication No.: US11353458B2Publication Date: 2022-06-07
- Inventor: Danton Bounds , Jenny L. Craigen , William E. Fieles , Fiona M. Germaschewski , Gaelle Herledan , Lydia Lee , Patrick A. Mayes , Lee McCahon , Katherine (Nee Sully) Nevin , Jennifer Paterson , Manuel Rodriguez-Justo , Laura M. Seestaller-Wehr , James Tunstead , Kwee L. Yong
- Applicant: GlaxoSmithKline Intellectual Property Development Limited
- Applicant Address: GB Middlesex
- Assignee: GlaxoSmithKline Intellectual Property Development Limited
- Current Assignee: GlaxoSmithKline Intellectual Property Development Limited
- Current Assignee Address: GB Middlesex
- Agency: Banner & Witcoff, Ltd.
- International Application: PCT/IB2016/056511 WO 20161028
- International Announcement: WO2017/072716 WO 20170504
- Main IPC: G01N33/574
- IPC: G01N33/574 ; A61K39/395 ; G01N15/14 ; A61P35/00 ; C07K16/28 ; G01N33/50 ; A61K39/00
Abstract:
Methods are provided for determining prognosis of multiple myeloma in a patient by measuring expression of BCMA in a sample. Also provided are methods for treating multiple myeloma by measuring expression of BCMA in a sample and administering an effective amount of an antigen binding protein that binds BCMA. Also provided are kits for measuring BCMA expression in a sample.
Public/Granted literature
- US20180306791A1 PROGNOSTIC METHOD Public/Granted day:2018-10-25
Information query
IPC分类:
